These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6701887)

  • 1. HLA antigens in pityriasis versicolor.
    Kanitakis J; Giannopoulos Z; Tourkantonis A; Kanitakis C
    Tissue Antigens; 1984 Jan; 23(1):47-9. PubMed ID: 6701887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity to the mycelial phase of Malassezia spp. in patients with pityriasis versicolor and controls.
    Saadatzadeh MR; Ashbee HR; Cunliffe WJ; Ingham E
    Br J Dermatol; 2001 Jan; 144(1):77-84. PubMed ID: 11167686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Missing granulocytic infiltrate in pityriasis versicolor--indication of specific anti-inflammatory activity of the pathogen?].
    Wroblewski N; Bär S; Mayser P
    Mycoses; 2005; 48 Suppl 1():66-71. PubMed ID: 15826291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dithranol-induced erythema sparing hypopigmented lesions of pityriasis versicolor.
    Shenoy SD; Wali I; Srinivas CR
    Contact Dermatitis; 1993 Apr; 28(4):253. PubMed ID: 8508648
    [No Abstract]   [Full Text] [Related]  

  • 5. Histological and serological studies of Pityrosporum orbiculare in cases of pityriasis versicolor.
    Furukawa F; Danno K; Imamura S; Soh Y
    J Dermatol; 1981 Feb; 8(1):27-30. PubMed ID: 7014679
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated immunity to Pityrosporum orbiculare in tinea versicolor.
    Sohnle PG; Collins-Lech C
    J Clin Invest; 1978 Jul; 62(1):45-53. PubMed ID: 96143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran.
    Tarazooie B; Kordbacheh P; Zaini F; Zomorodian K; Saadat F; Zeraati H; Hallaji Z; Rezaie S
    BMC Dermatol; 2004 May; 4():5. PubMed ID: 15119958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pityriasis versicolor in children: a retrospective study of 164 cases].
    Bouassida S; Boudaya S; Ghorbel R; Meziou TJ; Marrekchi S; Turki H; Zahaf A
    Ann Dermatol Venereol; 1998 Sep; 125(9):581-4. PubMed ID: 9805544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the lymphocyte transformation response to Pityrosporum orbiculare in patients with tinea versicolor.
    Sohnle PG; Collins-Lech C
    Clin Exp Immunol; 1982 Sep; 49(3):559-64. PubMed ID: 7172495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Pityrosporum orbiculare in patients with tinea versicolor and controls of various ages.
    Faergemann J
    J Invest Dermatol; 1983 Feb; 80(2):133-5. PubMed ID: 6337219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cell accumulation in chronic tinea pedis and pityriasis versicolor.
    Brasch J; Martens H; Sterry W
    Clin Exp Dermatol; 1993 Jul; 18(4):329-32. PubMed ID: 8403468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens.
    Mayser P; Gross A
    Acta Derm Venereol; 2000; 80(5):357-61. PubMed ID: 11200834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor.
    Shi TW; Zhang JA; Tang YB; Yu HX; Li ZG; Yu JB
    J Dermatolog Treat; 2015 Apr; 26(2):143-6. PubMed ID: 24802530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local treatment of versicolor pityriasis with penicillin].
    DE BONIS U; GABALLO S
    Minerva Med; 1952 May; 43(39):1013-4. PubMed ID: 14956870
    [No Abstract]   [Full Text] [Related]  

  • 15. Can pityriasis versicolor be treated with 2% ketoconazole foam?
    Cantrell WC; Elewksi BE
    J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study.
    Kurutas EB; Ozturk P
    Mycoses; 2016 Nov; 59(11):720-725. PubMed ID: 27329971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of pityriasis versicolor in young Italian sailors.
    Ingordo V; Naldi L; Colecchia B; Licci N
    Br J Dermatol; 2003 Dec; 149(6):1270-2. PubMed ID: 14674907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis versicolor, achromic?
    LINDSAY HC
    Arch Derm Syphilol; 1947 Jul; 56(1):116. PubMed ID: 20251569
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pityriasis versicolor in Greece and its predisposition factors].
    Parisis N; Stratigos J; Marcelou-Kinti U; Capetanakis J
    Hautarzt; 1977 Nov; 28(11):589-92. PubMed ID: 23362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of adapalene in the treatment of pityriasis versicolor.
    Shi TW; Ren XK; Yu HX; Tang YB
    Dermatology; 2012; 224(2):184-8. PubMed ID: 22572567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.